LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹26 Cr | ₹51 Cr | ₹73 Cr | ₹73 Cr | ₹149 Cr |
What is the latest Total Non-Current Liabilities ratio of LYKA LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹73 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | ₹149 Cr |
How is Total Non-Current Liabilities of LYKA LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | -48.85 | |
| Mar2024 | ₹51 Cr | -30.63 | |
| Mar2023 | ₹73 Cr | 0.66 | |
| Mar2022 | ₹73 Cr | -51.12 | |
| Mar2021 | ₹149 Cr | - | |
Compare Total Non-Current Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹260.4 Cr | -1.1% | 4.3% | -36.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -1.1% |
4.3% |
-36.4% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses